. Author manuscript; available in PMC: 2015 Dec 1.

Published in final edited form as: Respir Med. 2014 Oct 6;108(12):1779–1785. doi: 10.1016/j.rmed.2014.09.016

Table 4.

Adjusted Hazards Ratio on risk of CHD/CVD Outcomes

	Total CHD HR (95% CI)	CHD Death HR (95% CI)	Total CVD HR (95% CI)	CVD Death HR (95% CI)
FEV₁
FEV₁ Q3 vs. Q4	1.26^* (1.06-1.51)	1.23^* (1.03-1.47)	1.27^* (1.05-1.54)	1.18 (0.97-1.44)
FEV₁ Q2 vs. Q4	1.20 (0.98-1.46)	1.25^* (1.02-1.52)	1.15 (0.92-1.43)	1.19 (0.95-1.48)
FEV₁ Q1 vs. Q4	1.68^** (1.33-2.13)	1.83^** (1.45-2.31)	1.74^** (1.34-2.25)	1.75^** (1.35-2.26)
FVC
FVC Q3 vs. Q4	1.19 (1.00-1.43)	1.16 (0.97-1.38)	1.11 (0.92-1.35)	1.13 (0.93-1.38)
FVC Q2 vs. Q4	1.21 (0.97-1.51)	1.20 (0.96-1.50)	1.06 (0.83-1.37)	1.11 (0.87-1.43)
FVC Q1 vs. Q4	1.55^** (1.21-2.00)	1.69^** (1.32-2.16)	1.49^** (1.13-1.96)	1.68^** (1.28-2.21)

Variables adjusted for standard CVD risk factors: age, systolic blood pressure, diastolic blood pressure, body mass index, HDL, LDL, sex, diabetes, smoking, exercise, and prevalent CVD

p<.05

^**

p<.01